Tenet Healthcare Co. (NYSE:THC – Get Rating) was up 4.2% on Wednesday following a stronger than expected earnings report. The company traded as high as $88.21 and last traded at $87.91. Approximately 22,730 shares changed hands during trading, a decline of 98% from the average daily volume of 1,227,223 shares. The stock had previously closed at $84.33.
The company reported $1.93 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $1.04 by $0.89. Tenet Healthcare had a net margin of 4.69% and a return on equity of 56.04%. The company had revenue of $4.75 billion for the quarter, compared to the consensus estimate of $4.74 billion. During the same period last year, the firm posted $1.30 EPS. Tenet Healthcare’s revenue for the quarter was down .8% on a year-over-year basis.
THC has been the subject of several recent analyst reports. Raymond James upgraded shares of Tenet Healthcare from an “outperform” rating to a “strong-buy” rating and raised their price objective for the company from $105.00 to $120.00 in a research note on Thursday, January 20th. The Goldman Sachs Group reiterated a “buy” rating on shares of Tenet Healthcare in a research note on Tuesday, March 1st. Truist Financial raised their price objective on shares of Tenet Healthcare from $90.00 to $100.00 in a research note on Thursday, April 7th. Deutsche Bank Aktiengesellschaft raised their price objective on shares of Tenet Healthcare from $80.00 to $100.00 and gave the company a “buy” rating in a research note on Wednesday, February 9th. Finally, Credit Suisse Group lifted their target price on shares of Tenet Healthcare from $109.00 to $111.00 and gave the stock an “outperform” rating in a research report on Wednesday, February 9th. Three analysts have rated the stock with a hold rating, fourteen have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. According to data from MarketBeat, Tenet Healthcare has an average rating of “Buy” and a consensus price target of $97.00.
Several hedge funds and other institutional investors have recently bought and sold shares of THC. Fifth Third Bancorp raised its holdings in Tenet Healthcare by 33.5% in the fourth quarter. Fifth Third Bancorp now owns 629 shares of the company’s stock valued at $51,000 after acquiring an additional 158 shares in the last quarter. Asset Management One Co. Ltd. acquired a new stake in Tenet Healthcare in the third quarter valued at $59,000. Covestor Ltd acquired a new stake in Tenet Healthcare in the fourth quarter valued at $64,000. Allworth Financial LP acquired a new stake in Tenet Healthcare in the fourth quarter valued at $79,000. Finally, UMB Bank N A MO acquired a new stake in Tenet Healthcare in the fourth quarter valued at $86,000. 94.38% of the stock is currently owned by institutional investors and hedge funds.
The company has a debt-to-equity ratio of 7.55, a current ratio of 1.38 and a quick ratio of 1.31. The firm’s fifty day moving average is $85.89 and its 200-day moving average is $78.61. The stock has a market capitalization of $9.31 billion, a price-to-earnings ratio of 10.29, a PEG ratio of 4.93 and a beta of 2.42.
About Tenet Healthcare (NYSE:THC)
Tenet Healthcare Corporation operates as a diversified healthcare services company. The company operates in three segments: Hospital Operations and Other, Ambulatory Care, and Conifer. Its general hospitals offer acute care services, operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies.
Recommended Stories
- Get a free copy of the StockNews.com research report on Tenet Healthcare (THC)
- MarketBeat Podcast: 3 Stocks Flashing Buy Signals
- Should You Buy Carvana or AutoNation or Pass on Both?
- What Should Investors Take Away From Boston Beer’s Earnings?
- High-Yield Kinder Morgan Is Still A Buy
- NextEra Energy Offers a Long-Term Gain if You Can Tolerate Short-Term Pain
Receive News & Ratings for Tenet Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tenet Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.